共 38 条
[3]
Relative safety profiles of high dose statin regimens. Escobar C,Echarri R,Barrios V. Vasc Health Risk Manag . 2008
[4]
Lipid-lowering agents that cause drug-induced hepatotoxicity. Bhardwaj SS,Chalasani N. Clinics in Liver Disease . 2007
[5]
Statins in the treatment of dyslipidemia in the presence of elevated liver amino-transferase levels:a therapeutic dilemma. Calderon RM,,Cubeddu LX,Goldberg RB,et al. Mayo Clinic Proceedings . 2010
[7]
Howto use statinsin patients with chronicliver disease. Russo MW,JacobsonIM. Cleveland Clinic Journal of Medicine . 2004
[8]
Statin adverse effects:A review of the litera-ture and evidence for a mitochondrial mechanism. Golomb BA,Evans MA. Am J Cardio-vasc Drugs . 2008
[9]
Reduced mitochondrial coenzyme Q10 levels in HepG2 cells treated with high-dose simvastatin:A possible role in statin-induced hepatotoxicity?. Tavintharan S,Ong CN,Jeyaseelan K,et al. Toxicology and Applied Pharmacology . 2007
[10]
Autoimmune hepatitis triggered by statins. Alla V,Abraham J,Siddiqui J, et al. Journal of Clinical Gastroenterology . 2006